Multitarget mechanism of MYC inhibition by the bacterial lon protease in disease
Inès Ambite,
No information about this author
Murphy Lam Yim Wan,
No information about this author
Tran Thi Hien
No information about this author
et al.
Scientific Reports,
Journal Year:
2025,
Volume and Issue:
15(1)
Published: Feb. 25, 2025
Abstract
Identifying
specific
inhibitors
of
the
MYC
oncogene
has
been
challenging,
due
to
off
target
effects
associated
with
inhibition.
This
study
investigated
how
recombinant
Escherichia
coli
Lon
protease
(rLon),
which
targets
in
human
cells,
inhibits
over-activation
models
infection
and
cancer.
In
silico
predictions
identified
peptide
domains
bacterial
that
affinity
these
peptides
for
was
by
surface
plasmon
resonance.
The
N-terminal
domain
rLon
shown
interact
C-terminal,
leucine
zipper
MAX
prevent
MYC/MAX
dimerization.
Furthermore,
targeted
degraded
c-MYC
vitro
cellular
models,
through
peptidase
domain.
a
model
kidney
infection,
treatment
prevented,
c-MYC,
N-MYC
L-MYC
over-expression,
MYC-dependent
gene
expression,
specifically
renal
toxicity
genes
pathology,
suggesting
recognizes
corrects
dysregulation
this
disease.
findings
describe
multitarget
mechanism
inhibition
rLon,
combined
achieved
domains,
targeting
different
epitopes
functions,
no
evidence
or
detrimental
on
homeostatic
expression.
Language: Английский
Myc and Tor drive growth and cell competition in the regeneration blastema ofDrosophilawing imaginal discs
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 16, 2025
Abstract
During
the
regeneration
of
injured
or
lost
tissues,
blastema
serves
as
a
hub
for
robust
growth.
Drosophila
imaginal
discs
are
genetically
tractable
and
simple
model
system
study
organization
this
regrowth.
Key
signals
that
contribute
to
regenerative
growth
in
these
discs,
such
ROS,
Wnt/Wg,
JNK,
p38,
JAK/STAT,
Hippo
pathway,
have
been
identified.
However,
detailed
exploration
spatial
regrowth,
factors
directly
drive
growth,
consequences
activating
drivers
has
not
undertaken.
Here,
we
find
is
controlled
by
transcription
factor
Myc
Tor
signaling,
which
additively
proliferation
translation
blastema.
The
arranged
into
concentric
zones
defined
expression,
elevated
activity,
translation.
In
addition,
increased
expression
innermost
zone
induced
Xrp1-independent
cell
competition-like
death
adjacent
zones,
revealing
delicate
balance
between
driving
inducing
regenerating
tissue.
Summary
statement
wing
disc
characterized
factor,
signaling
Myc-induced
competition
.
Language: Английский
Novel Artificial 5′UTR Increase Modified mRNA Translation When Injected into Mouse Heart
Ann Kurian,
No information about this author
Matteo Ghiringhelli,
No information about this author
Edna Shalom
No information about this author
et al.
Pharmaceutics,
Journal Year:
2025,
Volume and Issue:
17(4), P. 490 - 490
Published: April 8, 2025
Background/Objectives:
Modified
messenger
RNA
(modRNA)
is
a
promising
gene
delivery
method
used
to
upregulate
genes
in
cardiac
tissue,
with
applications
both
clinical
and
preclinical
settings
prevent
remodeling
after
ischemic
injury.
The
5′
untranslated
region
(5′UTR)
plays
crucial
role
regulating
the
translation
efficiency
of
mRNA
into
functional
proteins.
Due
high
production
cost
short
half-life
modRNA,
it
essential
identify
novel
5′UTR
designs
that
enhance
modRNA
heart.
Methods:
Here,
we
present
an
artificial
5′UTR,
termed
“Top
Heart
5′UTR”,
designed
based
on
ribonucleotide
frequency
analyses
1000
highly
expressed
This
contains
unique
20-nucleotide
sequence,
consisting
11
previously
uncharacterized
nucleotides
(CCCCCGCCCCC)
9
well-described
from
Kozak
sequence
upstream
start
codon
(ATG).
Results:
design
significantly
improves
cardiomyocytes
(CMs)
heart
cells
vitro
vivo.
Specifically,
Top
increases
by
approximately
30–60%
mouse
human
CMs
compared
standard
control.
Moreover,
induces
2–2.5
times
higher
24
48
h
post-delivery.
Conclusions:
Our
findings
may
contribute
development
superior
platform
for
use
studies,
potentially
allowing
reduced
dosages
or
increased
expression
at
same
dosage
level.
approach
can
be
extended
optimized
5′UTRs
various
cell
types
organs,
including
cancer
therapies.
Language: Английский
A flexible, high-throughput system for studying mRNA translation kinetics in vitro and in cellulo with HiBit technology
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: June 27, 2024
Abstract
HiBit
is
an
engineered
luciferase’s
11
amino
acid
component
that
can
be
introduced
as
a
tag
at
either
terminus
of
protein
interest.
When
the
LgBit
and
substrate
are
present,
dimerise
forming
functional
luciferase.
The
technology
has
been
extensively
used
for
high-throughput
turnover
studies
in
cells.
Here,
we
have
adapted
use
to
quantify
mRNA
translation
temporally
vitro
rabbit
reticulocyte
system
cellulo
HEK293
cells
constitutively
expressing
LgBit.
assay
detect
differences
Cap,
5’UTR,
modified
nucleotide
composition,
coding
sequence
optimisation
poly(A)
length.
Importantly,
using
these
assays
established
optimal
composition
varied
depending
on
encoded
interest,
highlighting
importance
screening
methods
tailored
not
reliant
reporter
proteins.
Our
findings
demonstrated
easily
readily
monitor
offers
novel
highly
favourable
method
development
mRNA-based
therapeutics.
Graphical
abstract
Language: Английский
Role of Harmaline in Inhibiting c-Myc, Altering Molecular Typing, and Promoting Apoptosis in Triple-Negative Breast Cancer
Haoyi Xu,
No information about this author
Yan Ma,
No information about this author
Huiling Li
No information about this author
et al.
Breast Cancer Targets and Therapy,
Journal Year:
2024,
Volume and Issue:
Volume 16, P. 855 - 866
Published: Dec. 1, 2024
Objective:
Triple-negative
breast
cancer
(TNBC)
lacks
effective
targeted,
endocrine
therapeutic
agents
and
the
development
of
novel
is
costly
time-consuming.
The
objective
this
study
was
to
identify
pharmaceuticals
natural
products
utilized
in
clinical
practice
that
have
potential
inhibit
expression
Cellular-myelocytomatosis
oncogene
(c-Myc),
based
on
a
review
current
literature.
aim
assess
effect
specified
drugs
c-Myc
TNBC
cells,
determine
most
potent
inhibitor,
evaluate
its
impact
cell
proliferation,
invasive
migration,
apoptosis,
as
well
estrogen
receptor
(ER),
progesterone
(PR),
human
epidermal
growth
factor
2
(HER-2)
at
both
gene
protein
levels.
Explore
for
treatment
or
adjuvant
therapy
triple-negative
cancer.
Methods:
Quantitative
real-time
polymerase
chain
reaction
(qRT-PCR)
Western
blot
were
used
quantify
Flow
cytometry
employed
measure
proliferation
while
Transwell
assay
invasion
migration.
Results:
Harmaline
emerged
strongest
significantly
decreasing
levels
cells.
It
also
inhibited
invasion,
migration
promoting
apoptosis
Additionally,
there
varying
increase
ER
PR
genes
proteins.
While
HER-2
elevated,
no
significant
change
Notably,
phosphorylated
increased.
Conclusion:
found
promote
cells
by
targeting
inhibition
c-Myc.
induced
re-expression
ER,
PR,
genes,
Keywords:
c-Myc,
harmaline,
molecular
typing,
Language: Английский